| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.51 | 0.001 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |